Review: Mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy - PubMed (original) (raw)

Review

doi: 10.1111/nan.12463.

Affiliations

Free article

Review

Review: Mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy

E Marsan et al. Neuropathol Appl Neurobiol. 2018 Feb.

Free article

Abstract

Over the last decade, there has been increasing evidence that hyperactivation of the mechanistic target of rapamycin (mTOR) pathway is a hallmark of malformations of cortical development such as focal cortical dysplasia (FCD) or hemimegalencephaly. The mTOR pathway governs protein and lipid synthesis, cell growth and proliferation as well as metabolism and autophagy. The molecular genetic aetiology of mTOR hyperactivation has only been recently clarified. This article will review the current and still evolving genetic advances in the elucidation of the molecular basis of FCD. Activating somatic mutations in the MTOR gene are to date the most frequent mutations found in FCD brain specimens.

Keywords: DEPDC5; GATOR1; focal cortical dysplasia; focal epilepsy; mTOR pathway; somatic mutations.

© 2018 British Neuropathological Society.

PubMed Disclaimer

Publication types

MeSH terms

Substances

Supplementary concepts

LinkOut - more resources